Vivienne I Rebel

Title: Vivienne I Rebel: Innovator in Cancer Treatment

Introduction

Vivienne I Rebel is a prominent inventor based in San Antonio, TX (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented technologies. With a total of 2 patents, her work focuses on developing novel therapeutic agents aimed at combating cancer.

Latest Patents

Her latest patents include groundbreaking compositions and methods for treating cancer. One patent describes a double-stranded RNA interference (RNAi) agent that targets the expression of specific genes associated with cancer. This agent comprises a first double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the CD320 gene and a second dsRNA for inhibiting the expression of the LRP2 gene. The use of this RNAi agent as a pharmaceutical composition offers promising treatment options for patients in need. Another patent involves porphyrin compounds and compositions that are also useful for treating cancer, showcasing her commitment to advancing cancer therapies.

Career Highlights

Vivienne has worked with notable companies in the biotechnology sector, including Bioaffinity Technologies, Inc. and Oncoselect Therapeutics, LLC. Her experience in these organizations has allowed her to collaborate with other experts in the field and contribute to the development of innovative cancer treatments.

Collaborations

Throughout her career, Vivienne has collaborated with esteemed colleagues such as William E Bauta and David J Elzi. These partnerships have further enhanced her research and development efforts in the fight against cancer.

Conclusion

Vivienne I Rebel stands out as a dedicated inventor whose work in cancer treatment is making a significant impact. Her innovative patents and collaborations reflect her commitment to improving patient outcomes and advancing medical science.